Case report: Focal segmental glomerulosclerosis and nephrotic syndrome following treatment with pamidronate for calcitriol toxicity

Case report: Focal segmental glomerulosclerosis and nephrotic syndrome following treatment with pamidronate for calcitriol toxicity

ObjectiveThis study aimed to describe a case of glomerulosclerosis resulting in nephrotic syndrome following the administration of pamidronate disodium to treat clinical calcitriol toxicity in a dog.Case summaryA 12-week-old intact male Labrador Retriever weighing 11.8 kg presented with lethargy and...

Full description

Bibliographic Details
Main Authors:	Katherine Ann Dawson, April Blong, Rebecca Walton
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Veterinary Science
Subjects:	hypercalcemia pamidronate protein losing nephropathy calcitriol (1 25(OH) 2D 3) toxicity
Online Access:	https://www.frontiersin.org/articles/10.3389/fvets.2022.956153/full

Similar Items

Pamidronate Rescue Therapy for Hypercalcemia in a Child With Williams Syndrome
by: Sami A. Sanjad, et al.
Published: (2018-05-01)

Effect of Pamidronate on Hypercalcemia, BUN and Cr in Patients with Malignancy
by: Shahrbanoo Keyhanian, et al.
Published: (2016-05-01)

Safety and Efficacy of Pamidronate in Neonatal Hypercalcemia Caused by Subcutaneous Fat Necrosis: A Case Report
by: Stefano Martinelli, et al.
Published: (2022-04-01)

Important hypercalcemia due to subcutaneous fat necrosis treated with pamidronate in an infant with severe hypoxic-ischemic encephalopathy
by: Pasqua Anna Quitadamo, et al.
Published: (2016-08-01)

Important hypercalcemia due to subcutaneous fat necrosis treated with pamidronate in an infant with severe hypoxic-ischemic encephalopathy
by: Pasqua Anna Quitadamo, et al.
Published: (2016-08-01)

Neonatal Hypercalcemia Secondary to Subcutaneous Fat Necrosis Successfully Treated with Pamidronate: A Case Series and Literature Review
by: Veronica Mugarab Samedi, et al.
Published: (2014-11-01)

Steroid responsive idiopathic calcitriol induced hypercalcemia: a case report and review of the literature
by: Omar El Fadel, et al.
Published: (2023-06-01)

Intravenous pamidronate for refractory rheumatoid arthritis
by: Mansour Salesi, et al.
Published: (2012-01-01)

Pamidronate “zebra lines”: A treatment timeline
by: Avgi Loizidou, BSc, MBChB, et al.
Published: (2017-12-01)

Successful management with bisphosphonate treatment in a child with tuberculosis-associated hypercalcemia
by: Suna Kılınç, et al.
Published: (2020-08-01)

Calcitriol-mediated hypercalcemia in a patient with bilateral adrenal non-Hodgkin's B-cell lymphoma case report
by: Ana Abaroa-Salvatierra, et al.
Published: (2016-04-01)

Evaluation of Two Different Pamidronate Treatment Protocols in Children with Osteogenesis Imperfecta
by: Neslihan Onenli Mungan, et al.
Published: (2014-06-01)

Pamidronate infusion improved two cases of intractable seronegative rheumatoid arthritise
by: Mansour Salesi, et al.
Published: (2011-01-01)

Comparison of Calcitonin and Pamidronate Treatments in Children with Osteogenesis Imperfecta
by: Neslihan Onenli Mungan, et al.
Published: (2013-08-01)

Effect of pamidronate and calcium on implant osseointegration in ovariectomized rats
by: Mehrnoush Momeni, et al.
Published: (2016-09-01)

Clinicopathologic characteristics, pathology, and prognosis of 77 dogs with focal segmental glomerulosclerosis
by: Sarah K. Lorbach, et al.
Published: (2020-09-01)

Use of pamidronate for osteoporosis treatment in public health care in Brazil
by: Leila Bianchet Zanatta, et al.

Hypercalcemia and Osteolytic Lesions as Presenting Symptoms of Acute Lymphoblastic Leukemia in Children: Case Report and Literature Review
by: Min Chen, et al.
Published: (2022-06-01)

Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents
by: Ji-Hee Yoon, et al.
Published: (2021-06-01)

Effectiveness and safety of pamidronate treatment in nonambulatory children with low bone mineral density
by: Myeongseob Lee, et al.
Published: (2024-02-01)

EFFECTS OF PAMIDRONATE ADMINISTRATION ON TOOTH ERUPTION AND MANDIBULAR GROWTH IN NEW BORN RATS
by: İbrahim Tuncer, et al.
Published: (2017-01-01)

Comparison of the effect of alendronate and pamidronate on bone density of patients with osteoporosis
by: Zohre Nobakht, et al.
Published: (2018-12-01)

Vitamin D Metabolite Profile in Cholecalciferol- or Calcitriol-Supplemented Healthy and Mammary Gland Tumor-Bearing Mice
by: Artur Anisiewicz, et al.
Published: (2020-11-01)

Sternocostoclavicular Hyperostosis: Positive Clinical and Radiological Response on Pamidronate
by: Anne T. Leerling, et al.
Published: (2021-02-01)

Intravenous Pamidronate Therapy in Taiwanese Patients with Osteogenesis Imperfecta
by: Hsiang-Yu Lin, et al.
Published: (2008-10-01)

Vitamin D, the Vitamin D Receptor, Calcitriol Analogues and Their Link with Ocular Diseases
by: Miłosz Caban, et al.
Published: (2022-06-01)

Uso do pamidronato na síndrome SAPHO Pamidronate treatment in SAPHO syndrome
by: Luana Gerheim Machado, et al.
Published: (2005-12-01)

Simultaneous PTHrp- and calcitriol-mediated hypercalcemia associated with probable spontaneous transformation of lung adenocarcinoma to squamous cell carcinoma: A case report
by: Run Yu
Published: (2024-06-01)

Genotype-phenotype correlations and long-term efficacy of pamidronate therapy in patients with osteogenesis imperfecta
by: Yunha Choi, et al.
Published: (2022-03-01)

Re-evaluated data of dissociation constants of alendronic, pamidronic and olpadronic acids
by: Boichenko Alexander, et al.
Published: (2009-03-01)

Efficacy of pamidronate in children with chronic non-bacterial osteitis using whole body MRI as a marker of disease activity
by: C. S. Bhat, et al.
Published: (2019-07-01)

Persistent Increase in Serum 25-Hydroxyvitamin D Concentration in a Dog Following Cholecalciferol Intoxication
by: Charlotte Gerhard, et al.
Published: (2020-01-01)

Hypovitaminosis D Is Associated with Higher Levels of Inflammatory Cytokines and with HAM/TSP in HTLV-Infected Patients
by: Elaine Coutinho Netto, et al.
Published: (2021-11-01)

Relationship between serum magnesium, calcium, and parathyroid concentrations in dogs with abnormally low serum 25‐hydroxyvitamin D concentration and chronic or protein‐losing enteropathy
by: Charles Jones, et al.
Published: (2023-01-01)

Suplementasi Calcitriol Menurunkan Risiko Osteoporosis Tikus Ovariektomi
by: Hartiningsih ., et al.
Published: (2017-01-01)

The Effects of Polyphenol, Tannic Acid, or Tannic Acid in Combination with Pamidronate on Human Osteoblast Cell Line Metabolism
by: Hermizi Hapidin, et al.
Published: (2022-01-01)

Effect of cyclic pamidronate administration on osteoporosis in children with β-thalassemia major: a single-center study
by: Mahmoud A. El-Hawy, et al.
Published: (2022-08-01)

Vitamin D Receptor TaqI Polymorphism Is Associated With Reduced Follicle Number in Women Utilizing Assisted Reproductive Technologies
by: Mila W. Reginatto, et al.
Published: (2018-05-01)

Synthetic Hydroxyapatite Inhibits Bisphosphonate Toxicity to the Oral Mucosa In Vitro
by: George Bullock, et al.
Published: (2020-05-01)

Cyclic pamidronate treatment for osteogenesis imperfecta: Report from a Brazilian reference center
by: Bruna Pinheiro, et al.
Published: (2019-04-01)